Latest Breaking News On - Andri vetsch - Page 1 : vimarsana.com

Switzerland: Chronic treatment with Tolvaptan is tied to an increased femoral bone mineral density (BMD), and remarkable changes in both acid-base parameters and mineral metabolism in patients with.

Bruno vogtMatteo bargagliNicolas fallerDanielg fusterAndri vetschManuela andereggDuyen huynhNassera dhayatPietro manuel ferraroUniversity of bernUyen huynh doNephrology dialysis transplantationBone mineral densityMineral metabolismAutosomal dominant polycystic kidney diseaseChronic treatment